SAN JOSE, Calif., Oct. 24, 2017 -- Restoration Robotics, Inc. (NASDAQ:HAIR), announced today that it will highlight the ARTAS™ Robotic Hair Transplant System (the “ARTAS System”) at two upcoming global medical meetings.
The first meeting is The Dermatologic & Aesthetic Surgery International League (DASIL) 6th World Congress, which will be held in Shanghai, China from October 24-28, 2017. The clinical efficacy, physician and patient experience with the ARTAS System will be shared in a symposium on Wednesday, October 25, 2017, from 12:30 – 1:30 pm local time. DASIL is a non-profit professional organization, founded for the global advancement of knowledge in dermatologic and aesthetic surgery. It includes members from more than 30 countries and spans several medical specialties. It partners with the American Society for Dermatologic Surgery (ASDS) in its international teaching and mentorship programs. Over 1,000 registrants are expected to attend the 6th World Congress. The Restoration Robotics team will be available to meet with healthcare professionals interested in the ARTAS Robotic Hair Restoration System at Booth #F7-8 at the DASIL Congress.
The second meeting is the 2017 Annual Meeting of the American Academy of Facial Plastic and Reconstructive Surgery (AAFPRS), which will be held in Phoenix, AZ from October 26-28, 2017. AAFPRS is the world's largest specialty association for facial plastic surgery. It represents more than 2,700 facial plastic and reconstructive surgeons throughout the world. AAFPRS members are board certified surgeons whose focus is surgery of the face, head, and neck. The Restoration Robotics team will be available to meet with healthcare professionals interested in the ARTAS Robotic Hair Restoration System at Booth #516 at the AAFPRS annual meeting.
Ryan Rhodes, President and Chief Executive Officer of Restoration Robotics, said, “The DASIL Congress and AAFPRS Annual Meeting will give us the opportunity to increase awareness of the ARTAS System to potential customers treating patients for hair restoration from around the world. We look forward to participating in both meetings.”
About Restoration Robotics
Restoration Robotics, Inc., is a medical device company developing and commercializing the ARTAS™ Robotic Hair Restoration System. We believe the ARTAS System is the first and only physician-assisted system to dissect, and assist in the harvesting of, follicular units directly from the scalp and create recipient implant sites using proprietary algorithms. The Company has unique expertise in machine vision, image guidance, visual servoing and robotics, as well as developing intuitive interfaces to manage these technologies.
Media Contact
Lisa Markle
Director of Marketing
Restoration Robotics, Inc.
+1- 408-883-6764
[email protected]
Investor Contact
The Ruth Group
Zack Kubow & Lee Roth
[email protected]
646-536-7000


FTC Blocks Edwards Lifesciences’ JenaValve Acquisition in Major Antitrust Ruling
Nvidia Appoints Former Google Executive Alison Wagonfeld as First Chief Marketing Officer
Boeing 737 MAX 10 Advances in FAA Testing as Certification Delays Continue
AustralianSuper Backs BlueScope Steel’s Rejection of $9 Billion Takeover Bid
Federal Appeals Court Blocks Trump-Era Hospital Drug Rebate Plan
FCC Approves Expansion of SpaceX Starlink Network With 7,500 New Satellites
EU Orders Elon Musk’s X to Preserve Grok AI Data Amid Probe Into Illegal Content
Johnson & Johnson Secures Tariff Exemption by Agreeing to Lower Drug Prices in the U.S.
Hyundai Motor Shares Surge on Nvidia Partnership Speculation
Trump Pushes $100 Billion U.S. Oil Investment Plan for Venezuela After Maduro Seizure
UBS Upgrades L’Oréal to Buy, Sees Strong Sales Momentum and 20% Upside
Supreme Court to Hear Cisco Appeal on Alien Tort Statute and Human Rights Liability
Samsung Forecasts Strong Q4 Profit on AI-Driven Memory Chip Boom
Hanwha Ocean Shares Rise on Plans to Expand U.S. Shipbuilding Capacity
Avelo Airlines to End DHS Deportation Flights and Close Arizona Base Amid Rising Costs
Walmart to Join Nasdaq-100 Index as It Replaces AstraZeneca Following Exchange Move
xAI Cash Burn Highlights the High Cost of Competing in Generative AI 



